Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Current Taxes (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Current Taxes for 15 consecutive years, with $718796.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Taxes rose 8.76% year-over-year to $718796.0, compared with a TTM value of $718796.0 through Oct 2025, up 8.76%, and an annual FY2025 reading of $718796.0, up 8.76% over the prior year.
  • Current Taxes was $718796.0 for Q4 2025 at Pharma-Bio Serv, up from $713153.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $2.1 million in Q1 2021 and bottomed at $169760.0 in Q2 2021.
  • Average Current Taxes over 5 years is $827162.9, with a median of $642944.5 recorded in 2024.
  • The sharpest move saw Current Taxes tumbled 78.18% in 2021, then soared 865.51% in 2022.
  • Year by year, Current Taxes stood at $449896.0 in 2021, then decreased by 25.04% to $337264.0 in 2022, then soared by 58.27% to $533782.0 in 2023, then rose by 23.82% to $660903.0 in 2024, then increased by 8.76% to $718796.0 in 2025.
  • Business Quant data shows Current Taxes for PBSV at $718796.0 in Q4 2025, $713153.0 in Q3 2025, and $729282.0 in Q2 2025.